Trial intelligence / Profile preview

Ursodeoxycholic Acid in Intrahepatic Cholestasis of Pregnancy

NCT01226823Phase 3Withdrawn

Sponsor
Alma Mater Studiorum – Università di Bologna
Start
Nov 2010
Primary completion
Nov 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ursodeoxycholic acid in intrahepatic cholestasis of pregnancy (ICP), sponsored by Alma Mater Studiorum – Università di Bologna. Planned start Nov 2010; status: withdrawn.

02

Drugs

ursodeoxycholic acid
03

Conditions

intrahepatic cholestasis of pregnancy (ICP)

Beyond the preview

Go deeper on NCT01226823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01226823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call